Table 34-10.
Treatment Schedules for Pneumocystis jirovecii Pneumonia
Drug | Dosage | Notes |
---|---|---|
Trimethoprim-sulfamethoxazole | Trimethoprim 20 mg/kg iv q24h and sulfamethoxazole 100 mg/kg iv q24h in 2–3 divided doses for 3 days then reduced to trimethoprim 15 mg/kg iv q24h and sulfamethoxazole 75 mg/kg iv. q24h in 2–3 divided doses for 18 further days Same daily doses of trimethoprim-sulfamethoxazole po q24h, in 3 divided doses for 21 days 1920 mg (2 trimethoprim-sulfamethoxazole double strength tablets) po q8h for 21 days |
Dilute 1:25 in 0.9% saline infused over 90–120 min |
Clindamycin-primaquine | Clindamycin 600–900 mg iv q6h or q8h iv and primaquine 15–30 mg po q24h for 21 days | Methemoglobinemia Less likely if dose of 15 mg po q24h of primaquine is used |
Clindamycin 300–450 mg po q6h to q8h and primaquine 15–30 mg po q24h for 21 days | ||
Pentamidine | 4 mg/kg iv q24h for 21 days | Dilute in 250 mL 5% dextrose in water and infuse over 60 min |
Trimethoprim-dapsone | Trimethoprim 20 mg/kg po q24h in 3 divided doses and dapsone 100 mg po q24h for 21 days | |
Trimetrexate-folinic acid | 45 mg/m2 or 1.2 g/kg iv q24h for 21 days with folinic acid 20 mg/m2 or 0.5 mg/kg q6h for 24 days | Folinic acid must be continued for 3 days after last dose of trimetrexate |
Atovaquone | 750 mg po q12h for 21 days | Give with food to increase absorption |
Glucocorticoids Prednisolone |
40 g po q12h, days 1–5 40 g po q24h, days 6–10 20 g po q24h, days 11–21 |
Regimen recommended by CDC/NIH/IDSA, widely used in USA |
Methylprednisolone | iv at 75% of dose given above for prednisolone | |
Methylprednisolone Prednisolone |
1 iv q24h, days 1–3 0.5 iv days 4–6 then 40 g po q24h reducing to 0, days 7–16 | Regimen widely used in United Kingdom |
NB, None of these regimens for adjuvant glucocorticoid therapy have been compared in prospective clinical trials.